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Defective Activation of Mitogen-Activated Protein Kinase After Allogeneic Bone Marrow Transplantation
By Claudio Pignata, Jasbinder S. Sanghera, Robert J. Soiffer, Steve Chartier, Mathias Eder, Steven L. Pelech, and Jerome Ritz Allogeneic bone marrow transplant (BMT) recipients have increased susceptibility t o infections for prolonged periods after phenotypic reconstitution of donor cells. This immunodeficiency status is characterized by multiple T-cell functional abnormalities. This study was designed t o investigate several signaling pathways involved in T-cell activation during this period of immune deficiency. In initial experiments using equal numbers of CD3+ cells or highly purified T-cell subpopulations obtained from normal controls and BMT recipients, we confirmed that abnormal T-cell proliferation after CD3 cross-linking, phytohemagglutinin stimulation, or phorbol myristate acetate (PMA) stimulation of peripheral blood mononuclear cells from BMT recipients was due t o a qualitative T-cell deficiency rather than t o l o w numbers of circulating T cells. We next investigated the ability of the Tcell receptorlCD3 complex t o transduce signals via receptor-LLOGENEIC bone marrow transplantation (BMT) is now extensively used in the treatment of severe combined immunodeficiency syndromes, selected genetic disorders, aplastic anemia, and many hematologic malignancies.' Although this treatment is often successful, transplant-related morbidity and mortality represent significant obstacles limiting long-term results. Both graft-versus-host disease (GVHD) and opportunistic infections contribute to treatment-related Selective T-cell depletion of donor BM has significantly decreased the incidence of GVHD, thereby reducing the overall mortality rate: but patients remain severely immune deficient and susceptible to opportunistic infections for prolonged periods after BMT. Immunodeficiency affects both T-and B-cell compartments and often persists for 12 to 18 months after BMT.4,7 Many immune abnormalities have been identified after allogeneic BMT, including low proliferative responses to mitogens, antigens, and allogeneic stimuli4'*; abnormal in vitro Ig synthesis*; and defective cytotoxic activity of effector cell^.^^'^ In many studies, prophylactic administration of immunosuppressive agents may have contributed to these functional defects, but many abnormalities have also been found in patients who have not received immunosuppressive drugs. 7 Despite the characterization of impaired T-cell functions present in the post-BMT period and their similarity with other immunodeficiency conditions, the cellular mechanisms for these deficiencies have not been elucidated. Recent observations indicate that T-cell defects in BMT recipients are qualitative in nature, presumably due to abnormal cell activation pathways rather than to delayed repopulation of T-cell subset^.^." Membrane receptors participate in cell activation through transducing mechanisms that involve protein phosphorylatioddephosphorylation in an ordered sequence of events propagated from the membrane to the nucleus.'2 This sequence results in gene transcription that is regulated by activation of nuclear DNA-binding proteins. Molecular alterations of genes encoding for proteins involved in the signaling apparatus have been described in patients with primary immunodeficiency syndromes, thus indicating a role of signaling molecules in either cell activation or diffe~ntiation.'"'~ Moreover, posttranslational alterations resulting in selective defect of gene transcription have been reported."
T-cell differentiation and repopulation in recipient of CD6 T-cell-depleted marrow represent an unique model in which to investigate T-cell reconstitution in humans. These patients do not receive prophylactic immunosuppressive agents for prevention of GVHD, but phenotypic reconstitution of mature T cells occurs rapidly after BMT without the subsequent development of GVHD in the vast majority of patients. The present studies were designed to characterize various signal transduction pathways after phenotypic reconstitution of mature T cells and to determine whether abnormalities of signal transduction were associated with T-cell immunodeficiency after allogeneic BMT. 16 subjects who had received allogeneic BMT were examined in this study. All experiments were performed on serial blood samples obtained between 3 and 7 months after BMT. All subjects (age range, 21 and 53 years) had received HLA-identical BM depleted of CD6' ting. was kindly provided by Dr Brian Druker (DFCI). Affinitypurified rabbit polyclonal antibodies anti-erkl-111 (RI) against protein kinase subdomain 111 region and anti-erkl-CT (R2) against C-terminus rat brain erk-l were generated as previously described."' For Western blot experiments, alkaline phosphatase (AP)-conjugated antimouse or antirabbit Ig affinity-purified antibodies were purchased along with developing reagents, nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl-phosphate (BCIP; Promega, Madison, WI). Phytohemagglutinin (PHA) and phorbol myristate acetate (PMA) were purchased (Wellcome, Dartford, UK). Myelin basic protein (MBP) and other reagents not specified here were obtained from Sigma Chemical CO (St Louis, MO).
MATERIALS AND METHODS

Patients and controls. Peripheral blood (PB) samples from
Phenorypic unnl.vsis, cell cycle studies, and proliferation assay. PBMC were obtained at regular intervals during the year post-BMT by Ficoll-Hypaque density gradient separation and subjected to phenotypic analysis using an EPICS-C flow cytometer (Coulter). In proliferation assays, PBMC were incubated at 37°C for 72 hours with medium alone or in the presence of 1 pg/mL PHA, 20 ng/mL PMA, and 0.5 pmol/L ionomycin or in plates previously precoated by overnight incubation with 1 pg/mL anti-CD3. ['HI-thymidine (0.5 pCi) was added 18 hours before harvesting. Cell cycle analysis was performed by staining DNA with 50 pg/mL propidium iodide. mmol/L DIT) and loaded onto a MonoQ column attached to the Pharmacia FPLC system (Pharmacia, Uppsala, Sweden). After washing with 2 mL of buffer A, the column was developed with a 10-mL linear 0 to 0.8 mol/L NaCl gradient in buffer A. Fractions (250 pL) were collected and assayed for MBP phosphotransferase activity, as previously described."
RESULTS
T-cell proliferative response and cell cycle progression.
Initial experiments were performed to exclude the possibility that the functional impairment of T cells observed after allogeneic BMT was primarily due to either low numbers of T cells or CD4' T cells. Proliferative responses were evaluated after T-cell stimulation through either T-cell receptor (TCR)/ CD3-triggering, PHA mitogen, or PMA, which bypasses the very early events associated with the CD3/TCR signal transduction. Results in BMT recipients were compared with those of normal controls, matching the absolute number of CD3' T cells ( l X l@ per well). Figure 1 shows that none of the 3 methods of stimulating T cells was able to induce significant [3H]-thymidine incorporation in patient T cells. We further investigated whether purified CD3' T cells could be induced into cell-cycle progression after CD3/TCR stimulation. Purified CD3' T cells were obtained by cell sorting and stimulated by CD3 cross-linking. Cells were harvested after 72 hours of culture and DNA content was analyzed by propidium iodide staining. Compared with normal control cells, very few patient cells were in the G2-M phase (13% use only. of control values; data not shown). We next investigated whether the persistent low number of CD3TD4' T cells was responsible for the abnormal proliferation. Highly purified CD3TD4' or CD3'CDg' cells, obtained by cell sorting and containing greater than 98% pure populations, were cultured for 72 hours in the presence of 5% autologous adherent cells and PHA. Table 1 shows that, in contrast to controls, both CD4' and CD8' T-cell populations from all three BMT recipients responded poorly to mitogen stimulation. Results in BMT patients were only approximately 5% to 10% and 1% to 2% of control values, respectively.
Transmembrane signaling through TCWCD3 complex.
Previous studies have shown that the TCWCD3 complex is coupled to downstream elements of cell activation via protein tyrosine kinase pathways. In addition, the 5 subunit of the TCWCD3 complex is phosphorylated after receptor triggering. To evaluate the transducing function of the TCW CD3 complex in BMT recipients, we examined protein tyrosine phosphorylation patterns after T-cell activation through cross-linking of the E chain of the CD3 complex in all patients and controls. MAPK activiry in controls and BMT recipients. To investigate downstream elements of signaling pathways after T-cell activation, we next focused on MAPK. MAPKs are a group of serine-threonine kinases regulated by both tyrosine and threonine phosphorylation. MAPKs are known to be involved in the propagation of signals to nuclear transactivating factors." MAPK activity was evaluated by an in vitro phosphotransferase assay of cytosolic extracts from PBMC after stimulation through CD3 cross-linking or PMA. MAPK activity was assayed on fractions obtained after anion exchange chromatography and detected using the MAPK substrate MBP, as described in the Materials and Methods. whereas in control samples, the increase of MBP phosphorylation after CD3 cross-linking ranged between 7 and 15 pmol/min/mL. However, tyrosine phosphorylation of the 42-44-kD proteins was noted in each sample after CD3 crosslinking (Fig 5B and C) .
To show that the 42-44-kD proteins phosphorylated on tyrosine after CD3 cross-linking shown in Ptyr immunoblot experiments were 2 isoforms of MAPK, chromatographic fractions obtained from cytosol were used for MBP phosphorylation assay and immunoblotting with either anti-Ptyr or anti-MAPK antibodies. Figure 6 shows that, in both BMT recipient and control cells, the 42-44-kD isoforms of MAPK
TIME (min)
A loo L normal induction of protein tyrosine phosphorylation events through the TCWCD3 complex. In one additional BMT recipient, CD3 cross-linking induced a fivefold increase of MAPK activity as compared with unstimulated patient cells. Interestingly, PBMC from this subject also proliferated normally after CD3 perturbation.
In cells from normal individuals, there was excellent correlation between tyrosine phosphorylation of 42-44-kD proteins seen on phosphotyrosine blotting and the increase of MAPK activity as measured by in vitro phosphorylation of MBP. Figure 4 shows results of four different experiments performed with control cells comparing results of the MBP phosphorylation assay (Fig 4A) with assessment of tyrosine phosphorylation of 42-44-kD proteins by immunoblotting (B). Figure 4C shows the densitometric analysis of the tyrosine phopshorylation shown in Fig 4B . These experiments were selected for presentation because different responses to the two different stimuli were noted in the same experiment. As shown in these experiments, there was very good correlation between the 42-44-kD protein phosphorylation and increase in MAPK activity. In the first two normal subjects (lanes 1 through 5 and 6 through 9, respectively), PMA stimulation induced an increase in MBP phosphorylation that paralleled tyrosine phosphorylation of 42-44-kD proteins, whereas CD3 cross-linking was ineffective. In the other two normal PBMC samples (lanes 10 through 14 and 15 through 19, respectively), both stimuli elicited increased MAPK activity and, in parallel, 42-kD tyrosine phosphorylation. Figure 5 shows the results of S similar comparative experiments performed with cells obtained from BMT recipients. In all patient samples, the increase of MBP phosphorylation after CD3 cross-linking was very low or undetectable (Fig 5A) . were present in equal amounts and phosphorylated on tyrosine residues, even though no MAPK activity was observed in PBMC from the BMT recipient.
We next investigated whether PMA, which directly activates the serine-threonine kinase C, was able to stimulate MAPK activity. 
-
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C o n t r o l s P a t i e n t s Fig 7. MAPK phosphotransferase activity after PMA stimulation of PBMC from BMT recipients and controls. MAPK activity was determined after stimulation of PBMC for 5 minutes by measuring the increase in in vitro phosphorylation of the MBP substrate. MAPK was obtained by MonoQ fractionation of cytosolic proteins, as described in the Materials and Methods. Values (expressed as picomoles per minute per milliliter) obtained from 10 controls were compared with those obtained in l 1 BMT recipients. The P value, which was calculated using the Student's t-test, was c.05.
DISCUSSION
Patients who have undergone allogeneic BMT are at high risk for infections, which represent frequent and sometimes life-threatening complications during the post-BMT reconstitution pha~e.~" Immunologic abnormalities affecting both T-and B-cell compartments of the immune system persist for many months after BMT and appear to be responsible for the higher susceptibility to infections during this p e r i~d .~ Many functional abnormalities have been identified in BMT recipients, but these defects are not primarily due to delayed repopulation of the different cell subsets. This has suggested that qualitative rather than quantitative abnormalities account for this immune
In the present study, we have examined T-cell activation mechanisms in cells obtained during this period of immune deficiency after allogeneic BMT. T-cell responses are initiated by recognition and binding of antigens to TCR, which provides antigen ~pecificity.'~ TCR is expressed as a complex containing the invariant multimeric CD3 structure, which participates in signal transduction." Within the eight-chain TCWCD3 complex, only the E and 6 chains are capable of activating T cells and are involved in signal t r a n s d~c t i o n .~~~~~ The < subunit is promptly phosphorylated on tyrosine residues after T-cell activation through CD3.27 Many receptors transduce signals through tyrosine kinase domains of their intracytoplasmic tail or through association with intracytoplasmic tyrosine kinases. In the case of TCWCD3, candidates for coupling receptor to signaling pathway are the 59-kD which belongs to the Src family of intracytoplasmic tyrosine kin a s e~,~~ and the 70-kD <-associated protein (ZAP) kinase.3o Previous studies have suggested that virtually all of the steps in the signaling process from surface receptors to downstream elements can be altered and cause a T-cell immunodefi~iency.'~ Recent evidence indicates that mutations in genes encoding for molecules involved in signal transduction in T cells, such as IL-2Ry chain, JAK 3, and ZAP-70 kinases, may cause congenital forms of severe combined immunodefi~iency.'~"'
In preliminary experiments using purified T-cell populations, we confirmed that the functional abnormalities were caused by a qualitative defect rather than by delayed T-cell subset repopulation. Our initial approach to signal transduction through CD3 was to evaluate the pattern of tyrosylphosphorylated proteins after CD3 triggering. In all of the experiments performed, T-cell stimulation resulted in tyrosine phosphorylation of several proteins in a comparable fashion to what was observed in controls. A prominent effect was noted on a 21-kD protein that is generally accepted to correspond to the 5 chain of the TCWCD3 complex phosphorylated on tyrosine residues. Other proteins tyrosine phosphorylated after stimulation via CD3 had a molecular weight of [42] [43] [44] 60, [72] [73] [74] 85 , and 110 kD. Previous studies have shown that the structure of the TCR complex itself was normal in both the variable and invariant components early after BMT. Regeneration of the TCR repertoire, which is responsible for the clonotypic diversity of T cells, was recently found to be normal after allogeneic BMT, further supporting the concept that the structure of the receptor itself is normal in BMT recipient^.^' Moreover, calcium flux responses on the single-cell basis was found normal early after BMT." Our observation that tyrosine phosphorylation events associated with CD3 triggering were normal as well indicated that the block in cell activation occurred downstream. Increasing evidence indicates that the serine-threonine MAPK are able to translocate into the nucleus, thus transmitting signals to nuclear protein^.^'.^^ In this investigation, we found that, despite tyrosine phosphorylation of 42-44-kD isoforms of MAPK, there was no increase in the enzymatic activity, which was different from what was observed in controls, in which tyrosine phosphorylation was always associated with an increase in MAPK activity. Deficiency of MAPK activity was also found after stimulation of T cells by PMA, which bypasses early activation events associated with CD3 triggering. Of note, only one BMT recipient had CD3-inducible MAPK activity. MAPK activity in this subject, tested 6 months after BMT, was as high as fivefold of control values. Functional assays performed on frozen PBMC, obtained in the same period, showed results different from those of other subjects. A normal response to CD3 and PMA, which is indicative of an early recovery from immunodeficiency, was found. Of note, in all BMT recipients with defective activation of MAPK after T-cell stimulation, MAPK activity was detectable in resting cells and comparable to control baseline activity, suggesting that the failure of enzyme activation after T-cell stimulation in BMT recipients is due to abnormal posttranslational regulatory mechanisms.
MAPKs are a family of serine-threonine kinases that requires both tyrosine and threonine phosphorylation to express full enzymatic a~t i v i t y . '~.~~ The capability to integrate signals from the different tyrosine and serine-threonine pathways in a single network led to the consideration that MAPK play a key role in cell activation and differentiati~n.~~ Recent overview positioning MAPK in the signaling cascade indicated that MAPKs are relatively distal elements in signal
The major substrates positively regulated through serine or threonine phosphorylation by MAPK are the ribosomal S6 k i n a~e~~.~' and the transcription factors cmy^,^' ~6 2 "~:~ and Interestingly, c-jun is a component of the nuclear factor of activated T cells (NF-AT)" whose activation is necessary for the transcription of IL-2 gene in T cells.45 In BMT recipients, failure of IL-2 gene transcription has been documented,* even though recent evidence indicates that a strong polyclonal activation, such as PHA or PMA, may induce RNA transcription of several cytokines, including IL-2, IL-4, and IL-6, in short-term recipient~?~ Whether MAPK activation is a necessay event for proper cytokine production remains to be clarified through further studies. Recent evidence indicates that antigen stimulation of CD4' and CD8' host-reactive T-cell clones of donor origin failed to induce cytokine production, including IL-2 and interferon-y, whereas the cytotoxic activity of CD8+ cells was normal!'
Moreover, a normal phosphorylation of signaling proteins of the MAPK cascade was noted in these T-cell clones. Even though data on MAPK activity are not available from this study, these findings may support the hypothesis that the knowledge on the relationship beuse only.
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Recent studies on regulatory mechanisms involved in MAPK activation have shown several interconnections between MAPK and upstream signaling elements. MAPK are under direct control of an activating factor, the so-called M A P kinase-kinase, which is a dual specificity kinase able to phosphorylate MAPK in both tyrosine and threonine resid u e~. '~.~' T h e serine-threonine Raf-l kinase is now delineating as the link between receptor-associated kinases and the activation of MAP kinase k i n a~e .~' .~' The CD4/CD8 receptor-associated p56lCk tyrosine kinase is also able to phosphorylate on MAPK tyrosine residue^.^' Our finding argues that the defect of MAPK activation might be due to abnormal regulation of MAPK by upstream elements. The presence of tyrosine phosphorylation of MAPK not associated with kinase activation may also suggest that different sites in the molecule can be phosphorylated on tyrosine residues by different kinases leading, as shown for other kinases, to different regulatory effects.
Thus far, a number of recent observations indicate that congenital immunodeficiency syndromes may be related to mutations of genes encoding for molecules involved in signal transd~ction.'~"' Despite these observations, still poor information is available on the role that a posttranslational dysregd a t i o n of signaling pathways may play in aquired forms of qualitative-type T-cell activation deficiencies. Moreover, in our experimental system, signaling studies have been performed in an unique condition in which, due to the T-celldepletion procedure of BM, T-cell precursors in vivo differentiate into phenotypically and functionally mature T cells in a relatively short period of time after BMT. Therefore, our results may also provide valuable insights in understanding the role of signaling pathways in T-cell ontogeny in humans.
